v3.25.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 29, 2025
Mar. 30, 2024
Operating Activities:    
Net income $ 332,769 $ 275,961
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation 37,463 33,892
Amortization 8,835 10,933
Gain on sale or disposal of property and equipment (15) (12)
Unrealized foreign currency (gains) losses (38,983) 2,974
Deferred income taxes (11,593) (9,611)
Stock compensation expense 37,772 30,719
Realized loss on marketable securities 98 0
Changes in operating assets and liabilities, net of acquisitions:    
Accounts receivable, net of allowance for doubtful accounts 213,089 108,453
Inventories (102,239) 16,545
Other current and non-current assets (17,510) 2,117
Accounts payable (12,629) (1,281)
Other current and non-current liabilities (57,318) (64,699)
Deferred revenue (8,160) (2,549)
Deferred costs 4,102 (1,451)
Income Taxes 35,107 33,314
Net cash provided by operating activities 420,788 435,305
Investing activities:    
Purchases of property and equipment (40,062) (33,168)
Purchase of marketable securities (179,827) (85,626)
Redemption of marketable securities 88,788 77,131
Net (payments for) cash from acquisitions (2,100) 5,011
Other investing activities, net 599 (223)
Net cash used in investing activities (132,602) (36,875)
Financing activities:    
Dividends (144,566) (140,212)
Purchase of treasury shares related to equity awards (33,144) (15,987)
Purchase of treasury shares under share repurchase plan (27,098) 0
Net cash used in financing activities (204,808) (156,199)
Effect of exchange rate changes on cash and cash equivalents 12,672 (13,913)
Net increase in cash, cash equivalents, and restricted cash 96,050 228,318
Cash, cash equivalents, and restricted cash at beginning of period 2,080,154 1,694,156
Cash, cash equivalents, and restricted cash at end of period $ 2,176,204 $ 1,922,474